Tyler Fenske

Principal Associate Scientist, Immunotherapy

About Tyler

Tyler brings a wealth of experience in assay design and optimization in the infectious disease and immuno-oncology spaces, for products ranging from preclinical research to commercialization. He is responsible for the development of translational assays for various immunotherapy programs and contributes to the advancement of second-generation product candidates.

Prior to ElevateBio, Previously, Tyler was a researcher at Genocea Biosciences, where he was instrumental in developing assays to characterize vaccine products and generate vital immune monitoring data for advancement of a clinical stage HSV-2 vaccine and an early stage neoantigen immunotherapy.  Previous to Genocea, Tyler was an analyst at Emergent BioSolutions, establishing bioassays to define a new manufacturing process for BioThrax®, and contributed to the development of next generation anthrax vaccines.


Education & Accomplishments
Tyler received his B.S. in Biochemistry and Molecular Biology/Biotechnology from Michigan State University.

Check out our open roles

Interested in working with people like Tyler? We’re looking for pioneers and innovative thinkers committed to developing the next-generation of cell and gene therapies. Review our open roles and find your future.

apply now
“I joined ElevateBio because I believe life-changing medicines should have an efficient and effective path to patients in need.”
Life @ElevateBio
Meet the talented people who make ElevateBio a great place to work.
meet the team